We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$83.7B
AUM Growth
-$1.57B
Cap. Flow
-$3.66B
Cap. Flow %
-4.37%
Top 10 Hldgs %
8.74%
Holding
5,820
New
545
Increased
1,802
Reduced
1,597
Closed
679

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$365M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$307M
3
ADBE icon
Adobe
ADBE
+$250M
4
NVDA icon
NVIDIA
NVDA
+$242M
5
CRM icon
Salesforce
CRM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 13.14%
2 Financials 9.37%
3 Healthcare 7.49%
4 Consumer Discretionary 6.79%
5 Communication Services 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIA
4226
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$249K ﹤0.01%
+25,301
New +$248K
CNS icon
4227
Cohen & Steers
CNS
$4.17B
$248K ﹤0.01%
+3,953
New +$283K
RDVT icon
4228
Red Violet
RDVT
$889M
$248K ﹤0.01%
14,342
-7,667
-35% -$153K
TALK icon
4229
Talkspace
TALK
$874M
$248K ﹤0.01%
240,449
-358,109
-60% -$526K
VICI icon
4230
VICI Properties
VICI
$29.5B
$248K ﹤0.01%
8,311
-364,275
-98% -$12M
ADV icon
4231
Advantage Solutions
ADV
$504M
$247K ﹤0.01%
4,638
+2,675
+136% +$247K
ENTA icon
4232
Enanta Pharmaceuticals
ENTA
$370M
$246K ﹤0.01%
4,741
NG icon
4233
NovaGold Resources
NG
$2.62B
$246K ﹤0.01%
52,552
-49,854
-49% -$231K
TSVT
4234
DELISTED
2seventy bio
TSVT
$245K ﹤0.01%
+16,866
New +$250K
XERS icon
4235
Xeris Biopharma Holdings
XERS
$1.42B
$245K ﹤0.01%
157,255
+108,392
+222% +$179K
PANA
4236
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$245K ﹤0.01%
25,008
VERV
4237
DELISTED
Verve Therapeutics
VERV
$243K ﹤0.01%
7,062
-87,063
-92% -$2.78M
DM
4238
DELISTED
Desktop Metal, Inc.
DM
$243K ﹤0.01%
9,399
-48,834
-84% -$1.37M
ALXO icon
4239
ALX Oncology
ALXO
$272M
$241K ﹤0.01%
25,223
-9,163
-27% -$107K
PEBO icon
4240
Peoples Bancorp
PEBO
$1.46B
$241K ﹤0.01%
+8,332
New +$245K
IMTXW
4241
DELISTED
Immatics N.V. Warrants
IMTXW
$240K ﹤0.01%
88,599
+698
+0.8% +$2.18K
ELVT
4242
DELISTED
Elevate Credit, Inc.
ELVT
$240K ﹤0.01%
218,125
-162,842
-43% -$295K
INNV icon
4243
InnovAge Holding
INNV
$1.56B
$239K ﹤0.01%
40,632
-18,404
-31% -$84.2K
RICK icon
4244
RCI Hospitality Holdings
RICK
$201M
$238K ﹤0.01%
+3,647
New +$227K
ECL icon
4245
Ecolab
ECL
$76.4B
$237K ﹤0.01%
1,639
-43,138
-96% -$7M
SPWR
4246
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
$237K ﹤0.01%
+10,300
New +$232K
CSR
4247
PUT
Centerspace
CSR
$937M
$236K ﹤0.01%
+3,500
New +$278K
WB icon
4248
CALL
Weibo
WB
$1.92B
$236K ﹤0.01%
13,800
-19,300
-58% -$373K
XAGE
4249
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
$236K ﹤0.01%
811
JBSS icon
4250
John B. Sanfilippo & Son
JBSS
$978M
$235K ﹤0.01%
3,108

Similar funds

D.E. Shaw & Co's Q3 2022 Portfolio in Review

As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.

  • D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
  • D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
  • D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
  • D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
  • D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
  • D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
  • D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.